A randomized trial of rosuvastatin in the prevention of venous thromboembolism.
New England Journal of Medicine.
Times cited: 498
Reduction in C-reactive protein and LDL cholesterol and cardiovascular event rates after initiation of rosuvastatin: a prospective study of the JUPITER trial.
Times cited: 697